Abiopharma

🔍 Hanson Kyle (Director)

Company: Katapult Holdings, Inc. (KPLT)

Report Date: 2026-08-11

Detailed Transactions and Holdings:

• Acquired 3,505,145 shares of Common Stock (Direct)
  Date: 2026-08-11 | Code: A | equity_swap_involved: 0 | shares_owned_after: 3,505,145.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 900,308 shares of Common Stock (Direct)
  Date: 2026-08-11 | Code: J | equity_swap_involved: 0 | shares_owned_after: 4,405,453.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 628,931 shares of Common Stock (Direct)
  Date: 2026-08-11 | Code: A | equity_swap_involved: 0 | shares_owned_after: 628,931.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Received in exchange for the contribution and assignment of 114.4 units of CCFI MIP Holdings LLC to the Issuer in exchange for shares of the Issuer's common stock in connection with the mergers of Aaron's Intermediate Holdco, Inc. and CCF Holdings, LLC with subsidiaries of the Issuer (the "Mergers"). On the effective date of the Mergers, the closing price of the Issuer's common stock was $8.00 per share.
• F2: Reflects a pro rata distribution from KMJ Group Holdings, LLC, a manager-managed Ohio limited liability company, of which the reporting person is a member. Not a market sale.
• F3: Reflects an award of restricted stock units pursuant ("RSUs") as part of the Mergers that will vest over two years, with 25% of the RSUs vesting on February 11, 2027, and the remaining RSUs vesting thereafter in three substantially equal semi-annual installments on the 11th of each of February and August of each year, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date.